Sg Capital Management LLC Vericel Corp Transaction History

Sg Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 07, 2024	BUY	$23.85 - $31.34 $4.75 Million - $6.24 Million	199,266 New	199,266 $5.84 Million
Q1 2023 May 12, 2023	BUY	$23.85 - $31.34 $4.75 Million - $6.24 Million	199,266 New	199,266 $5.84 Million
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $1.53 Million - $2.85 Million	-179,924 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $1.13 Million - $2.99 Million	-155,548 Reduced 46.37%	179,924 $1.65 Million
Q4 2019 Feb 13, 2020	BUY	$13.77 - $19.2 $2.93 Million - $4.09 Million	213,000 Added 173.92%	335,472 $5.84 Million
Q3 2019 Oct 24, 2019	SELL	$14.93 - $19.83 $8.37 Million - $11.1 Million	-560,787 Reduced 82.08%	122,472 $1.85 Million
Q2 2019 Jul 22, 2019	BUY	$15.01 - $18.89 $10.3 Million - $12.9 Million	683,259 New	683,259 $12.9 Million

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Sg Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Capital Management LLC with notifications on news.